Trials / Active Not Recruiting
Active Not RecruitingNCT05166265
Clinical Investigation Study of Safety and Performance of the Sentio System.
A Prospective, Multi-center, Single-arm, Clinical Investigation of the Safety and Performance of the Sentio System in Users With Mixed/Conductive Hearing Losses and Single Sided Deafness
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Oticon Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, open label, single-arm, multi-centre investigation, designed to follow clinical practice for Sentio bone conduction devices in 50 subjects, during 10 clinical visits, and 24 months follow-up.
Detailed description
The investigation is a 24-months multinational, multicentre, prospective, open label, single arm investigation on the Sentio system. The purpose of this investigation is to evaluate safety and performance three months after implantation of the new Sentio system. In addition, safety will be analysed six months after implantation, and long-term safety and performance will be evaluated over a 24-month follow-up period. The endpoints chosen, together with applicable measurements, are commonly used, both in the clinical setting as well as in bone anchored hearing research as shown in the scientific literature covering this area. That is, the primary objectives of this study is to demonstrate that the Sentio system improves hearing and speech recognition on the implanted ear. Secondary objectives includes investigation of hearing improvement, speech intelligibility, patient satisfaction, and quality of life. The study also aims to evaluate the safety profile of the Sentio system in terms of the occurrence of adverse events and serious adverse events related to the device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active transcutaneous bone conduction hearing system | The Sentio system consists of the Sentio 1 sound processor (SP) and Sentio Ti implant with fixation band and screws. |
Timeline
- Start date
- 2022-01-19
- Primary completion
- 2024-02-19
- Completion
- 2025-11-01
- First posted
- 2021-12-21
- Last updated
- 2024-04-03
Locations
6 sites across 3 countries: Germany, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT05166265. Inclusion in this directory is not an endorsement.